Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — April 3, 2025

APPROVAL OF BOARD MINUTES

• Draft of March 6, 2024, Regular Session Minutes

REPORTS

• Applications approved pursuant to Licensure Policy 13-01
• Monthly report from Probation     
• Board Delegated Review pursuant to Licensure Policy 14-02
• Research Drug Study report pursuant to Staff Action Policy 18-02

FLEX

• Open Meeting Law vote for Pharmacy Advisory Committee
• Pharmacy Advisory Committee Meeting: April 16, 2025, 10am-11am
  • Recommendation Document 25-01: Rapid Sterility Testing
  • Election of Board member to the meeting
• Compounded Preparations from 503B Outsourcing Facilities memo
• FDA memo regarding GLP-1 supply
• Pharmacy Self-Inspection Requirements (247 CMR 9.19 (21))

POLICIES

• Policy 14-02: Board Delegated Review (BDR)

APPLICATION

• CAPS Pharmacy; DS3312 – Petition for Waiver
• Galaxy Pharmacy-New Retail Pharmacy and Complex Non-Sterile Compounding
• Jungle Jim’s Pharmacy - Non-Resident Retail Pharmacy
• Manet Pharmacy – New Retail Pharmacy
• Revive Rx Sterile Compounding License - New Application

VIII

FILE REVIEW

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant. The